Effect of budesonide combined with aerosol inhalation of terbutaline in treating bronchial asthma children
-
摘要: 目的 观察布地奈德联合特布他林雾化吸入对小儿支气管哮喘的疗效,并探讨对血清环氧化酶-2(COX-2)、趋化素样因子-1(CKLF-1)的影响。 方法 选取小儿支气管哮喘患儿100例为研究对象,采用随机数表法将患者分为2组,每组50例。对照组采用布地奈德治疗,观察组在此基础上联合特布他林雾化吸入治疗。比较2组治疗效果及患儿症状缓解时间、住院时间。观察治疗前后用力肺活量(FVC)、第1秒用力呼气量(FEV1)、第1秒用力呼气量占用力肺活量比值(FEV1/FVC)、COX-2、CKLF-1的变化,同时比较2组不良反应发生情况。 结果 观察组总有效率高于对照组,差异有统计学意义(P<0.05)。观察组胸闷、喘息、咳嗽改善时间及住院时间均短于对照组,差异有统计学意义(P<0.05)。与治疗前比较, 2组FVC、FEV1、FEV1/FVC均升高,且观察组高于对照组,差异有统计学意义(P<0.05)。治疗后, 2组患儿COX-2、CKLF-1表达水平低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率低于对照组,差异有统计学意义(P<0.05)。 结论 布地奈德联合特布他林雾化吸入治疗小儿支气管哮喘可有效缓解患儿临床症状,降低血清COX-2、CKLF-1表达水平,促进肺功能恢复,缩短患儿住院时间。Abstract: Objective To observe the effect of budesonide combined with aerosol inhalation of terbutaline in children with bronchial asthma and the influence on serum cyclooxygenase-2(COX-2)and chemokine like factor-1(CKLF-1). Methods A total of 100 children with bronchial asthma were selected as study objects, and were divided into two groups according to random number table method, with 50 cases in each group. The control group was treated with budesonide, and the observation group was treated with aerosol inhalation of terbutaline based on the control group. Treatment effect, symptom relief time and hospitalization time were compared. The changes of forced vital capacity(FVC), forced expiratory capacity in the first second(FEV1), ratio of forced expiratory capacity in the first second to forced vital capacity(FEV1/FVC), COX-2, CKLF-1 before and after treatment in two groups were recorded, and the occurrence of adverse reactions of two groups was recorded. Results The total effective rate in the observation group was significantly higher than that in the control group(P<0.05). Children in the observation group had shorter improvement time in chest tightness, wheezing, cough and hospitalization time than the control group(P<0.05). Compared with before treatment, the levels of FVC, FEV1, FEV1/FVC in two groups were all increased, and the observation group was higher than the control group, the differences were statistically significant(P<0.05). After treatment, the expression levels of COX-2 and CKLF-1 in the two groups were significantly lower than before treatment, and the observation group was significantly lower than - the control group(P<0.05). The incidence rate of adverse reactions in the observation group was significantly lower than that in the control group(P<0.05). Conclusion Budesonide combined with atomization inhalation of terbutaline can effectively alleviate the clinical symptoms of children with bronchial asthma, reduce the expression levels of serum COX-2 and CKLF-1, promote the recovery of lung function, and shorten the hospitalization time.
-
-
车向郁. 异丙托溴铵联合布地奈德、特布他林雾化吸入对支气管肺炎患儿细胞因子的影响[J]. 海南医学院学报, 2016, 22(17): 1989-1991. 高伟霞, 秦小菀, 张靖. 孟鲁司特钠颗粒联合吸入用布地奈德混悬液治疗小儿支气管哮喘的疗效及其对血清抗凝血酶Ⅲ、CD5抗原样蛋白和补体3水平的影响[J]. 新乡医学院学报, 2019, 36(4): 368-371. 冯爱民, 李晓娟, 杨会侠, 等. 布地奈德联合槐杞黄颗粒治疗小儿哮喘的疗效及对血清LTD4、NGF、TIMP-1水平的影响[J]. 现代生物医学进展, 2017, 17(25): 4908-4911. 王宽, 段智梅, 刘艳红, 等. 喘可治注射液联合布地奈德混悬液雾化吸入治疗支气管哮喘慢性持续期疗效观察[J]. 现代中西医结合杂志, 2017, 26(14): 1528-1530. JENKINS C R, ERIKSSON G, BATEMAN E D, et al. Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment[J]. BMC Pulm Med, 2017, 17(1): 65.
中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编委会. 儿童支气管哮喘诊断与防治指南: 2016年版[J]. 中华儿科杂志, 2016, 54(3): 167-181. 华医学会哮喘学组. 支气管哮喘防治指南(支气管哮喘的定义诊断、治疗、疗效判断标准及教育和管理方案)[J]. 中华结核和呼吸杂志, 2003, 26(3): 132-138. 邹艳萍, 罗小兰, 刘利. 布地奈德与丙酸倍氯米松辅助特布他林雾化吸入治疗小儿哮喘急性发作的对比研究[J]. 中国药房, 2016, 27(17): 2388-2391. RAZI C H, AKELMA A Z, HARMANCI K, et al. The addition of inhaled budesonide to standard therapy shortens the length of stay in hospital for asthmatic preschool children: a randomized, double-blind, placebo-controlled trial[J]. Int Arch Allergy Immunol, 2015, 166(4): 297-303.
伍祥胡, 梁霞, 凌洁萍. 异丙托溴铵溶液、沙丁胺醇、布地奈德混悬液联合雾化吸入治疗小儿毛细支气管炎的效果研究[J]. 解放军预防医学杂志, 2019, 37(4): 114-115. [11] KANSAL P, NANDAN D, AGARWAL S, et al. Correlation of induced sputum eosinophil levels with clinical parameters in mild and moderate persistent asthma in children aged 7-18 years[J]. J Asthma, 2018, 55(4): 385-390.
孙妍. 西替利嗪口服联合布地奈德吸入对小儿哮喘急性发作过程中免疫炎症反应的影响[J]. 海南医学院学报, 2017, 23(23): 3271-3274. NANDAN D, KANSAL P, PATHARIA N, et al. Induced sputum nitrite levels correlate with clinical asthma parameters in children aged 7-18 years with mild to moderate persistent asthma[J]. J Lab Physicians, 2016, 8(2): 90-95.
汪燕, 鲁利群, 黄莉, 等. 匹多莫德联合布地奈德雾化吸入对支气管哮喘患儿IL-4, IFN-γ, 免疫球蛋白及T细胞亚群的影响[J]. 现代生物医学进展, 2017, 17(23): 4541-4544. FABLE J M, FERNANDEZ M, GOODINE S, et al. Retrospective comparison of fluticasone propionate and oral viscous budesonide in children with eosinophilic esophagitis[J]. J Pediatr Gastroenterol Nutr, 2018, 66(1): 26-32.
迟新宇, 韩树生, 王健. 地氯雷他定片联合布地奈德混悬液雾化吸入治疗小儿毛细支气管炎的效果及对炎症介质的影响[J]. 中国医药导报, 2016, 13(26): 76-79. YOSHIHARA S, KANNO N, FUKUDA H, et al. Caregiver treatment satisfaction is improved together with children's asthma control: Prospective study for budesonide monotherapy in school-aged children with uncontrolled asthma symptoms[J]. Allergol Int, 2015, 64(4): 371-376.
于海心, 许敬, 赵翠红, 等. 雾化吸入布地奈德、特布他林结合机械辅助排痰治疗重症肺炎患儿的疗效及护理[J]. 河北医药, 2019, 41(6): 933-936. 郭梅, 王卫. 布地奈德雾化吸入对小儿哮喘患者外周血炎症因子及肺功能的影响[J]. 河北医学, 2017, 23(7): 1086-1090. -
期刊类型引用(24)
1. 张媛昊. 分析吸入用布地奈德混悬液联合硫酸特布他林雾化吸入用溶液治疗小儿毛细支气管炎的临床疗效及对血清IL-4、IL-6、IL-8、TNF-α、IFN-γ的影响. 黑龙江医药. 2025(01): 33-37 . 
百度学术
2. 木国法，李旭，龚应玲. 白细胞介素-4、瘦素、趋化素与肥胖型哮喘患儿病情程度的关系及预测哮喘控制的价值. 实用临床医药杂志. 2025(03): 108-113 . 本站查看
3. 尹莉娜. 小儿推拿疗法联合药物雾化治疗小儿慢性持续期支气管哮喘护理研究. 航空航天医学杂志. 2024(02): 233-235 . 百度学术
4. 薛绍芬，田英，陈雅. 糜蛋白酶联合特布他林雾化治疗支气管哮喘的临床效果. 实用临床医学. 2024(02): 14-18 . 百度学术
5. 何茸茸，徐莉，刘晶晶. 特布他林联合布地奈德雾化吸入对小儿哮喘治疗的效果分析. 智慧健康. 2024(11): 77-79 . 百度学术
6. 武文会，刘琳，耿贝贝. 氨茶碱联合特布他林与沙丁胺醇对老年支气管哮喘的治疗作用. 华夏医学. 2024(04): 185-190 . 百度学术
7. 李爱平，刘敏. 布地奈德联合特布他林雾化吸入治疗小儿支气管炎的疗效及作用机制分析. 临床研究. 2024(09): 58-61 . 百度学术
8. 巫小燕，邓暄辉. 特布他林联合布地奈德治疗支气管肺炎患儿的效果及对临床症状的影响. 医学信息. 2024(20): 131-134 . 百度学术
9. 谷志勇，刘一波. 血清CKLF-1、COX-2水平对支气管哮喘患儿临床分型的价值. 国际检验医学杂志. 2023(04): 446-449 . 百度学术
10. 常婷，杜秋燕. 特布他林结合布地奈德雾化吸入治疗小儿哮喘的临床效果. 临床医学研究与实践. 2023(12): 47-50 . 百度学术
11. 王萍，罗慧，宋春莉，陈立波. 不同剂量布地奈德对儿童支气管哮喘疗效和炎症抑制的影响. 中南医学科学杂志. 2023(05): 737-740 . 百度学术
12. 闫雪. 氨溴索联合特布他林、布地奈德治疗小儿支气管肺炎的临床效果. 妇儿健康导刊. 2023(01): 132-134 . 百度学术
13. 黄莹，郑秀琴，陈岚. 特步他林并布地奈德治疗对急性支气管哮喘患者IL-5、IL-10及TNF-α的影响. 分子诊断与治疗杂志. 2022(01): 161-164 . 百度学术
14. 赵日婵，梁方华，严有敏. 布地奈德与硫酸特布他林雾化吸入对小儿哮喘患儿血清变态反应的影响. 中国医药科学. 2022(04): 88-91 . 百度学术
15. 凌媛，陈列. 特布他林联合孟鲁司特钠治疗支气管哮喘患者的临床疗效. 临床合理用药杂志. 2022(09): 36-38 . 百度学术
16. 张洪琼，闫天凌，钱军. 特布他林、孟鲁司特钠联合治疗支气管哮喘的临床效果及呼吸力学指标观察. 解放军医药杂志. 2022(06): 96-99 . 百度学术
17. 罗媛珍，戴建华. 喘可治注射液联合布地奈德混悬液雾化治疗小儿支气管哮喘的临床观察. 现代诊断与治疗. 2022(08): 1145-1147 . 百度学术
18. 余准，黄锴川，林凯. 特布他林与异丙托溴铵雾化治疗支气管哮喘中重度急性发作的疗效及对肺功能的影响. 中国处方药. 2022(07): 114-116 . 百度学术
19. 车蓬丽，崔文兰. 孟鲁司特钠联合沙美特罗替卡松治疗小儿支气管哮喘的临床效果及对免疫功能、STAT1、IRF1的影响. 临床医学研究与实践. 2022(28): 77-80 . 百度学术
20. 齐莎莎，张国伟，孟凡威，付晓梅，张宏. 细菌溶解产物胶囊联合扎鲁司特、布地奈德气雾剂治疗支气管哮喘缓解期患儿的效果观察. 医学理论与实践. 2022(23): 4057-4059 . 百度学术
21. 乐丽君. 穴位贴敷联合雾化吸入治疗小儿喘息临床分析. 湖北理工学院学报. 2021(05): 55-59 . 百度学术
22. 刁秀伟，陈勇. 布地奈德联合盐酸氨溴索雾化吸入治疗小儿支气管肺炎的临床疗效. 江西医药. 2021(09): 1465-1467 . 百度学术
23. 丰红梅，赵梦. 布地奈德雾化吸入联合家庭教育对儿童哮喘的临床疗效观察. 中国妇幼保健. 2021(23): 5454-5458 . 百度学术
24. 赵芳，刘振国，常瑛，葛莉，李芳. 肺热清颗粒联用糖皮质激素对小儿支气管哮喘氧化/抗氧化失衡的影响. 湖南师范大学学报(医学版). 2021(06): 171-174 . 百度学术
其他类型引用(0)
计量
- 文章访问数: 387
- HTML全文浏览量: 81
- PDF下载量: 17
- 被引次数: 24
下载:
苏公网安备 32100302010246号